【 New Fields and Breakthroughs 】 Weihai Purple Light and Shandong Lingxi Biological Stem Cell Cooperation Project Officially Signed

  


During the 13th Five Year Plan period, the Central Committee of the Communist Party of China and the State Council issued the "Healthy China 2030" Plan Outline. Among them, "Stem cells and regenerative medicine" has been included in the planning outline as a major technological project. The research and development of stem cells will be a disruptive change for health and life, and will also be a hot trend in the future development of medical technology.


   

Weihai Ziguang adheres to the concept of healthy development, always remembering the purpose of serving the people's health, focusing on public expectations, and with the mission of improving quality of life and health and happiness index. On May 24th, Weihai Ziguang and Shandong Lingxi Biotechnology held a signing ceremony for a stem cell cooperation project. The two sides reached a consensus on jointly researching, preparing, and promoting stem cell projects, forming a cooperation. Leaders from the Science and Technology Innovation Bureau and Economic Development Bureau of Weihai Economic Development Zone, as well as leaders from Weihai Ziguang Science and Technology Park and Shandong Lingxi Biology, attended the signing ceremony.


      

At the beginning of the meeting, Chen Lin, Director of the Science and Technology Innovation Bureau of the Economic Development Zone, delivered a speech. He stated that Weihai Ziguang has been deeply cultivating the big health industry for 26 years and has been developing to this day. It adheres to innovative development as an opportunity, focuses on promoting enterprise technological innovation and new product development, and produces products that have formed industrial scale and brand influence. He hopes that both sides can take joint construction as an opportunity, fully leverage their respective strengths and capabilities in their respective fields, create a benchmark for strategic cooperation, and work together for the well-being of the people's health.


     
Mr. Wang Wenfeng, Director of Weihai Ziguang R&D Center, and Mr. Liu Chao, Chairman of Shandong Lingxi Biotechnology, signed a strategic cooperation agreement as representatives, marking the anchoring and departure of the Weihai Ziguang stem cell project towards deep blue.


     

According to the cooperation agreement signed this time, both parties will cooperate in the field of stem cells. Lingxi Biotechnology will provide systematic solutions in the entire stem cell biology industry chain and various links such as device design, assembly, testing, etc., achieving seamless connection from the innovation chain to the industry chain, accelerating the landing of Weihai Ziguang Stem Cell Laboratory. Both parties will fully integrate their advantages in the fields of biomedicine, health industry, etc., strengthen communication and cooperation in talent cultivation, team building, resource co construction and sharing, exchange and mutual visits, so as to achieve complementary advantages and strong alliances, and jointly draw a new blueprint for the development of the big health industry.

   

In the future, both sides will actively promote deep and multidimensional cooperation in the field of stem cell research based on mutual trust and long-term friendly cooperation. Join hands and work together to create a model of cooperation, open up a new chapter of cooperation, and explore new achievements in the future.





Weihai Ziguang


      Since its establishment in 1997, Weihai Ziguang has adhered to its original intention, dedicated itself to serving the country through industry, and always focused on the development of the health industry; After 26 years of bathing in the wind and rain, we have developed from a single health product production enterprise to a professional nutrition and health product service provider with 5 major parks and 6 major industrial sectors; In September 2022, the enterprise carried out the relocation and renovation of the park, achieving the transformation of old and new kinetic energy, completing the iteration and upgrading of automation, digitization, and intelligence, and officially entering the ranks of advanced manufacturing enterprises and professional service providers in the nutrition and health food industry.

     In the new development cycle, Weihai Ziguang actively responds to the call of party committees and governments at all levels of the province, city, and district to "take the lead and open up new opportunities", strives to achieve high-quality development of the enterprise, actively lays out cutting-edge fields and high-tech sectors in the health product industry, and injects new momentum into the rapid development of the enterprise; The stem cell project is a high-tech sector initiated by Weihai Ziguang, jointly committed by Shandong Lingxi Biology and South Korean professional forces, and is an important component of Ziguang's future development. Weihai Ziguang will always take safeguarding people's health as its responsibility, continuously develop new products, and safeguard national health with professional strength.





   Rhinoceros organism   


    Shandong Lingxi Biotechnology Co., Ltd. is a high-tech innovative enterprise that integrates biotechnology research and development, cell new drug research and development, medical transformation, health management, and medical beauty. The company is committed to the research and development of cells and related biological products through a model of production, learning, research, and medicine. At present, the company has established long-term partnerships with multiple research institutions and medical institutions both domestically and internationally. Through continuous exploration and breakthroughs in new technologies, Lingxi Biotechnology has acquired a number of independent intellectual property rights with core competitiveness. The company has established a comprehensive R&D innovation platform internally, participated in 8 national and provincial-level R&D projects, applied for 10 patents, authorized 1 invention patent, and published 4 related journal papers. Continuously building an internationally influential platform for the innovation and transformation of regenerative medicine, serving human health through technological innovation.



Scan the code to follow us

紫光优健二维码.jpg
Protecting the health of the whole population and improving the quality of life
Weihai Ziguang is always on the road